Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
NCT00446095
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class
Conditions
Lymphoma
Interventions
DRUG:
fostamatinib
Sponsor
Rigel Pharmaceuticals